The CDDF Engages at the Accelerating Global Health Equity Annual Summit
Dr. Catarina Edfjäll, representing the CDDF, participated in a panel discussion on EU Pharmaceutical Legislation at the Accelerating Global Health Equity Annual Summit, held as a World Economic Forum (WEF) side event in Davos on January 18, 2024. Dr. Edfjäll joined...
CDDF’s Selection As Ad Hoc Representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) Under the Accelerating Clinical Trials in the EU (ACT EU)
The Cancer Drug Development Forum is proud to announce its selection as an ad hoc representative of the Multi-Stakeholder Platform Advisory Group (MSP AG) under the Accelerating Clinical Trials in the EU (ACT EU). The ACT EU initiative is run by the European...
Gain valuable perspectives from CDDF participants and get an inside look at the CDDF Multi-stakeholder workshop on Biomarkers in Precision Oncology (Nov 2023)
Take a look at the interviews with participants from the CDDF Multi-stakeholder Workshop on “Biomarkers in Delivering Drug Development-Related Precision Oncology (13-14 November 2023, Amsterdam) and gain valuable perspectives from diverse stakeholders. Collaboration...
NEW PUBLICATION-WHITE PAPER: Histology Independent Drug Development – Is This the Future for Cancer Drugs?
The Cancer Drug Development Forum (CDDF) is delighted to announce that the White Paper has been developed following its ‘Histology Independent Drug Development – Is This the Future for Cancer Drugs?’ workshop, which took place on 14-15th November 2022, in Amsterdam....